• Explore /
  • Poster
  • / A phase I dose escalation study of SCB01A, a micro-tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy.

A phase I dose escalation study of SCB01A, a micro-tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy.

Abstract Poster

Authors

null

Nai-Jung Chiang

National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan

Nai-Jung Chiang , Her-Shyong Shiah , Chia-Chi Lin , Chia-Jui Yen , Hui-Jen Tsai , Shang-Yin Wu , Wu-Chou Su , Kwang-Yu Chang , Li-Tzong Chen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics and Translational Research

Sub Track

Chemotherapy

Clinical Trial Registration Number

NCT011159522

Citation

J Clin Oncol 35, 2017 (suppl; abstr 2531)

DOI

10.1200/JCO.2017.35.15_suppl.2531

Abstract #

2531

Poster Bd #

23

Abstract Disclosures

Similar Posters

First Author: Melissa Lynne Johnson

First Author: Yan Song

First Author: David Sommerhalder

First Author: Soohyeon Lee